Amazfit, a leading global smart wearables brand by Zepp Health (NYSE: ZEPP), and the Official Timing & Wearable Partner of HYROX, today announced the expansion of its HYROX athlete roster, with Hunter McIntyre (USA) returning for another season and four standout competitors joining the team: Rich Ryan (USA), Joanna Wietrzyk (Australia), Emilie Dahmen (Netherlands), and Linda Meier (Germany). This press release features multimedia. View the full release here: https://www.businesswire.com/ne...

Curatis Holding AG (SIX: CURN, 'Curatis') announces a new distribution contract with Phoenix Labs (Ireland) for four products in Switzerland. Significant revenue growth with new products Curatis has signed a contract with Phoenix Labs (Ireland) to distribute four products in the areas of pain management and urology in Switzerland, starting from October 2025. These products generated revenues of approximately CHF 5 million in Switzerland in 2024. As the marketing authorisation holder, Curati...

SG Entertech Co., Ltd., a South Korean VR startup established in 2019, officially announces the global launch of Snack VR, an innovative VR mini-platform for international markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250915132571/en/Snack VR is an innovative VR mini-platform that operates in just 5㎡ of space, presenting a new business model expandable across tourism, education, and cultural sectors (Photo: SG Entertech Co...

IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients and biosciences, today inaugurated its expanded LMR Naturals site in Grasse following a €10 million investment. The expansion increases the facility’s footprint by 75 percent to 4,687 square meters and includes a state-of-the-art pilot hall designed to accelerate the development of new natural ingredients. The upgraded site also counts on a newly completed experimental field nearby that will provide direct access to plant...

Hopae Inc., creator of the Hopae Connect – Global eID and Wallet orchestration platform, and INCERT GIE, Luxembourg’s public trust infrastructure agency, today announced a strategic partnership to make Hopae Connect the first officially registered Intermediary Service in the EU under the eIDAS 2.0 regulation. — eIDAS 2.0 is the EU regulation that aims to deliver to every European a government-backed Digital Identity Wallet by the end of 2026—and makes it mandatory for banks, airlines, telec...

SUI Group Holdings Limited (“SUI Group,” “SUIG” or the “Company”) (NASDAQ: SUIG), the only publicly traded company with an official relationship with the Sui Foundation, today announced it has completed its previously authorized $2 million stock repurchase program. SUI Group is also announcing that its Board of Directors has now authorized a new stock repurchase program to acquire up to an additional $50 million of the Company’s common stock. Following the completion of its initial stock repu...

At Lenovo™ Innovation World 2025, Lenovo introduced its latest portfolio of AI-powered innovations to date. Spanning high-performance PCs, intelligent tablets, immersive gaming devices, and Motorola smartphones, the new lineup reflects Lenovo’s vision of Smarter AI for All — bringing generative AI and hybrid intelligence into everyday workflows, creativity, and entertainment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/202509049621...

Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, announces the launch of medically-certified Dream Sock™ in South Africa. Distributed as a Class C Medical Device with CE Marking, this groundbreaking product enables parents to track Baby’s live vital signs and receive real-time health notifications, delivering greater peace of mind. Designed for healthy babies between 0 and 18 months (2.5-13.6 kg), Dream Sock is a trusted tool for families worldwide ...

KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and cGMP contract development and manufacturing organization (CDMO), and Infinimmune, Inc., a biotechnology company pioneering human-first antibody discovery and design, announced a collaboration to advance manufacturing of Infinimmune’s lead human monoclonal antibody (“IFX-101”) program. The first antibody in Infinimmune’s therapeutic drug development pipeline, IFX-101, targets atopic dermatitis and is designed to deliver superior effica...